BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32074104)

  • 1. Genomic and phenotypic characterization of Burkholderia isolates from the potable water system of the International Space Station.
    O'Rourke A; Lee MD; Nierman WC; Everroad RC; Dupont CL
    PLoS One; 2020; 15(2):e0227152. PubMed ID: 32074104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping.
    Brisse S; Verduin CM; Milatovic D; Fluit A; Verhoef J; Laevens S; Vandamme P; Tümmler B; Verbrugh HA; van Belkum A
    J Clin Microbiol; 2000 May; 38(5):1876-84. PubMed ID: 10790116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.
    Mahenthiralingam E; Bischof J; Byrne SK; Radomski C; Davies JE; Av-Gay Y; Vandamme P
    J Clin Microbiol; 2000 Sep; 38(9):3165-73. PubMed ID: 10970351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.
    Mahenthiralingam E; Coenye T; Chung JW; Speert DP; Govan JR; Taylor P; Vandamme P
    J Clin Microbiol; 2000 Feb; 38(2):910-3. PubMed ID: 10655415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy.
    Fiore A; Laevens S; Bevivino A; Dalmastri C; Tabacchioni S; Vandamme P; Chiarini L
    Environ Microbiol; 2001 Feb; 3(2):137-43. PubMed ID: 11321544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
    Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
    APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbial isolation and characterization from two flex lines from the urine processor assembly onboard the international space station.
    Nguyen HN; Sharp GM; Stahl-Rommel S; Velez Justiniano YA; Castro CL; Nelman-Gonzalez M; O'Rourke A; Lee MD; Williamson J; McCool C; Crucian B; Clark KW; Jain M; Castro-Wallace SL
    Biofilm; 2023 Dec; 5():100108. PubMed ID: 36938359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
    Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
    J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis.
    Nunvar J; Kalferstova L; Bloodworth RA; Kolar M; Degrossi J; Lubovich S; Cardona ST; Drevinek P
    PLoS One; 2016; 11(8):e0160975. PubMed ID: 27512997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide chemotypes of Burkholderia cepacia.
    Evans E; Poxton IR; Govan JRW
    J Med Microbiol; 1999 Sep; 48(9):825-832. PubMed ID: 10482293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.
    Coenye T; Mahenthiralingam E; Henry D; LiPuma JJ; Laevens S; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Jul; 51(Pt 4):1481-1490. PubMed ID: 11491349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of Burkholderia cepacia isolates from cystic fibrosis (CF) patients in an Italian CF center.
    Petrucca A; Cipriani P; Valenti P; Santapaola D; Cimmino C; Scoarughi GL; Santino I; Stefani S; Sessa R; Nicoletti M
    Res Microbiol; 2003 Sep; 154(7):491-8. PubMed ID: 14499935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
    Henry DA; Mahenthiralingam E; Vandamme P; Coenye T; Speert DP
    J Clin Microbiol; 2001 Mar; 39(3):1073-8. PubMed ID: 11230429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of clinical isolates of Burkholderia cepacia and assessment of their pathogenicity in animal experiments].
    Bondarev VP; Darmov IV; Kovtun AL; Shaginian IA; Marakulin IV; Chukhlantsev DA; Paramonov IV
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (3):16-20. PubMed ID: 18597993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated version of the Burkholderia cepacia complex experimental strain panel.
    Coenye T; Vandamme P; LiPuma JJ; Govan JR; Mahenthiralingam E
    J Clin Microbiol; 2003 Jun; 41(6):2797-8. PubMed ID: 12791937
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
    Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
    Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.